Finance

Lists
Why is BBNX down 3,60%?
Dive Deeper
BBNX:NASDAQ
Beta Bionics Inc
US$17,43
-3,60%
(-0,65) 1D
US$17,40
-0,17% (-0,030)
After hours
Closed: 8 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBNX...
Open
US$17,96
High
US$18,04
Low
US$17,07
Mkt. cap
917,41 ລ້ານ
Avg. vol.
1,30 ລ້ານ
Volume
0,00
52-wk high
US$32,71
52-wk low
US$8,80
EPS
US$-1,65
Shares outstanding
52,64 ລ້ານ
No. of employees
422
Open
US$17,96
High
US$18,04
Low
US$17,07
Mkt. cap
917,41 ລ້ານ
Avg. vol.
1,30 ລ້ານ
Volume
0,00
52-wk high
US$32,71
52-wk low
US$8,80
EPS
US$-1,65
Shares outstanding
52,64 ລ້ານ
No. of employees
422
News stories
From web sources and news partners
About Beta Bionics Inc
CEO-
Employees422
Founded2015
Headquartersເອີວິນ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorMedical device
Websitebetabionics.com
Analyst ratings
Based on 14 analysts giving stock ratings to BBNX in the past 3 months
Buy
Buy
10
Hold
4
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for BBNX in the last 3 months.
Highest
Current US$17,43
US$30,40 (+74,41%)
Average
US$23,72 (+36,09%)
Lowest
US$16,00 (-8,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Christopher Pasquale
Barclays
Buy
Initiated
US$30,00
+72,1%
10/06/2026
Unknown Analyst
Barclays
Buy
Initiated
US$30,00
+72,1%
10/06/2026
Richard Newitter
Truist Financial
Buy
Reiterated
US$28,00
+60,6%
09/24/2026
Larry Biegelsen
Wells Fargo
Buy
Initiated
US$28,00
+60,6%
09/23/2026
Frank Takkinen
Lake Street
Buy
Reiterated
US$25,00
+43,4%
09/22/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$27,00
+54,9%
09/17/2026
Jonathan Block
Stifel Nicolaus
Buy
Maintained
US$22,00
+26,2%
09/15/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
US$16,00
-8,2%
09/15/2026
Patrick Wood
UBS
Buy
Maintained
US$25,00
+43,4%
09/15/2026
Travis Steed
Bank of America Securities
Hold
Reiterated
US$20,00
+14,7%
09/14/2026
Mathew Blackman
TD Cowen
Hold
Maintained
US$18,00
+3,3%
09/14/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
09/14/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
US$30,40
+74,4%
07/30/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
US$20,00
+14,7%
07/30/2026
Danielle Antalffy
UBS
Buy
Initiated
US$22,00
+26,2%
07/28/2026
David Roman
Goldman Sachs
Buy
Reiterated
US$19,00
+9%
07/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
27,25 ລ້ານ
32,12 ລ້ານ
27,63 ລ້ານ
32,01 ລ້ານ
Cost of goods sold
12,13 ລ້ານ
13,18 ລ້ານ
11,19 ລ້ານ
13,11 ລ້ານ
Cost of revenue
12,13 ລ້ານ
13,18 ລ້ານ
11,19 ລ້ານ
13,11 ລ້ານ
Research and development expenses
8,20 ລ້ານ
10,13 ລ້ານ
10,36 ລ້ານ
10,24 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23,97 ລ້ານ
24,94 ລ້ານ
30,35 ລ້ານ
34,24 ລ້ານ
Operating expense
32,16 ລ້ານ
35,07 ລ້ານ
40,71 ລ້ານ
44,48 ລ້ານ
Total operating expenses
44,30 ລ້ານ
48,24 ລ້ານ
51,90 ລ້ານ
57,59 ລ້ານ
Operating income
-17,04 ລ້ານ
-16,12 ລ້ານ
-24,27 ລ້ານ
-25,58 ລ້ານ
Other non operating income
1,00 ພັນ
-
-
-2,00 ພັນ
EBT including unusual items
-14,21 ລ້ານ
-13,47 ລ້ານ
-21,90 ລ້ານ
-23,40 ລ້ານ
EBT excluding unusual items
-14,21 ລ້ານ
-13,47 ລ້ານ
-21,90 ລ້ານ
-23,40 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,21 ລ້ານ
-13,47 ລ້ານ
-21,90 ລ້ານ
-23,40 ລ້ານ
Net profit margin
-52,14%
-41,92%
-79,25%
-73,10%
Earnings per share
-0,33
-0,19
-0,36
-0,36
Interest and investment income
2,83 ລ້ານ
2,66 ລ້ານ
2,38 ລ້ານ
2,18 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
2,83 ລ້ານ
2,66 ລ້ານ
2,38 ລ້ານ
2,18 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-16,66 ລ້ານ
-15,59 ລ້ານ
-23,69 ລ້ານ
-24,87 ລ້ານ
Gain or loss from assets sale
-
31,00 ພັນ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google